HEALTH TIPS.: Biogen halts study of Alzheimer’s drug, once pinned as “the last great hope for AD”. At this point, 4 Anti-Aβ mAbs have failed 9 big Ph3 trials, 3 γ-Secretase inhibitors showed cognitive worsening, 4 BACE inhibitors showed cognitive worsening. Global pipeline for AD looks bleak.

Thursday, 21 March 2019

Biogen halts study of Alzheimer’s drug, once pinned as “the last great hope for AD”. At this point, 4 Anti-Aβ mAbs have failed 9 big Ph3 trials, 3 γ-Secretase inhibitors showed cognitive worsening, 4 BACE inhibitors showed cognitive worsening. Global pipeline for AD looks bleak.

Biogen halts study of Alzheimer’s drug, once pinned as “the last great hope for AD”. At this point, 4 Anti-Aβ mAbs have failed 9 big Ph3 trials, 3 γ-Secretase inhibitors showed cognitive worsening, 4 BACE inhibitors showed cognitive worsening. Global pipeline for AD looks bleak.

submitted by /u/SirT6
[link] [comments]

from Health https://ift.tt/2Y6lZZk
via IFTTT

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)